Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

From the Experts

Cath Lab Management
06/05/2013
Jennifer Westford, Recruiter, Corazon, Inc., Pittsburgh, Pennsylvania
Jennifer Westford, Recruiter, Corazon...
Is your organization currently seeking a cardiovascular nurse manager? If so, you are not alone! Over the past few years, Corazon has found that the cardiovascular nurse manager role, both in the cath lab and the cardiovascular ICU setting,...
Is your organization currently seeking a cardiovascular nurse manager? If so, you are not alone! Over the past few years, Corazon has found that the cardiovascular nurse manager role, both in the cath lab and the cardiovascular ICU setting,...
Is your organization currently...
06/05/2013
Cath Lab Digest
Cath Lab Management
04/04/2013
Kristin Truesdell and Cheyne Vernon, Corazon, Inc. Pittsburgh, Pennsylvania.
Kristin Truesdell and Cheyne Vernon, ...
With profit margins narrowing, there has been increasing scrutiny of proper reimbursement, most particularly in the cath lab, since more and more procedures are shifting to the outpatient setting.
With profit margins narrowing, there has been increasing scrutiny of proper reimbursement, most particularly in the cath lab, since more and more procedures are shifting to the outpatient setting.
With profit margins narrowing,...
04/04/2013
Cath Lab Digest
Cath Lab Management
03/01/2013
Cath Lab Digest talks with Annapoorna S. Kini, MD, MRCP, FACC, Director, Cardiac Catheterization Laboratory, Mount Sinai Hospital, New York, New York.
Cath Lab Digest talks with Annapoorna...
Compared to most hospitals across the U.S., we have not seen a volume drop. I personally am still doing over 1,000 procedures per year, coronary as well as structural heart disease procedures, such as valvuloplasties and transcatheter aortic...
Compared to most hospitals across the U.S., we have not seen a volume drop. I personally am still doing over 1,000 procedures per year, coronary as well as structural heart disease procedures, such as valvuloplasties and transcatheter aortic...
Compared to most hospitals...
03/01/2013
Cath Lab Digest
03/01/2013
Kelly Neal-Wilson, RN, MSN, MBA, Account Manager, Corazon, Inc., Pittsburgh, Pennsylvania
Kelly Neal-Wilson, RN, MSN, MBA, Acco...
Vascular has emerged as an attractive growth opportunity. Many hospitals still have not fully recognized the market share potential despite the large population of vascular disease patients.
Vascular has emerged as an attractive growth opportunity. Many hospitals still have not fully recognized the market share potential despite the large population of vascular disease patients.
Vascular has emerged as an...
03/01/2013
Cath Lab Digest
Cath Lab Management
01/06/2012

Jane Kiah, RN, Director of Invasive Services, Baptist Cardiac & Vascular Institute, Miami, Florida; Program Director, Innovations in Cardiac and Vascular Care: Advanced Interventions for Nurses and Technologists, The International Symposium on Endovascular Therapy (ISET)

Dick Stueve, RT, radiation safety consultant to Philips Healthcare, providing on-site radiation safety courses for physicians, nurses and technologists performing fluoroscopically guided vascular interventions.

Jane Kiah, RN, Director of Invasive S...
Marie Curie died due to excess exposure to her discovery, radium. Thomas Edison invented the fluoroscope, but stopped his work in this area when his assistant died of an x-ray overdose. Many years later, we have a better understanding of the...
Marie Curie died due to excess exposure to her discovery, radium. Thomas Edison invented the fluoroscope, but stopped his work in this area when his assistant died of an x-ray overdose. Many years later, we have a better understanding of the...
Marie Curie died due to excess...
01/06/2012
Cath Lab Digest
Calcium Corner
01/06/2012

Cath Lab Digest talks with Paul A. Gurbel, MD, Director, Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore; Associate Professor of Medicine, Johns Hopkins University School of Medicine; Baltimore, Maryland.

Cath Lab Digest talks with Paul A. Gu...
Thirty-day ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) data were presented at TCT in November. Can you describe the study?ADAPT-DES is a large, multi-center registry looking at the relation between...
Thirty-day ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) data were presented at TCT in November. Can you describe the study?ADAPT-DES is a large, multi-center registry looking at the relation between...
Thirty-day ADAPT-DES (Assessment...
01/06/2012
Cath Lab Digest
Calcium Corner
12/05/2011

Cath Lab Digest talks with Clemens von Birgelen, MD, PhD, Thoraxcentrum Twente and University of Twente, Enschede, The Netherlands.

Cath Lab Digest talks with Clemens vo...
What is the history of comparisons between the Xience V and Resolute stents?The TWENTE trial is actually the second, prospective, randomized trial between Resolute and Xience V in patients with complex coronary artery disease. The first, the...
What is the history of comparisons between the Xience V and Resolute stents?The TWENTE trial is actually the second, prospective, randomized trial between Resolute and Xience V in patients with complex coronary artery disease. The first, the...
What is the history of...
12/05/2011
Cath Lab Digest
Calcium Corner
10/28/2011

Cath Lab Digest talks with Gregg W. Stone, MD, FACC, FSCAI, Professor of Medicine, Columbia University, Director of Cardiovascular Research and Education, Center for Interventional Vascular Therapy, Columbia Medical Center and the Cardiovascular Research Foundation, New York, New York

Cath Lab Digest talks with Gregg W. S...
EXCEL is a global, prospective, multi-center, randomized trial to assess the safety and efficacy of the Xience Prime/Xience V everolimus-eluting stent (Abbott Vascular, Santa Clara, California) compared to coronary artery bypass grafting...
EXCEL is a global, prospective, multi-center, randomized trial to assess the safety and efficacy of the Xience Prime/Xience V everolimus-eluting stent (Abbott Vascular, Santa Clara, California) compared to coronary artery bypass grafting...
EXCEL is a global, prospective,...
10/28/2011
Cath Lab Digest
Clinical Update
10/03/2011

Cary Lunsford, RCIS, FSICP, and Laura Minarsch, RT(R), CVT

Cary Lunsford, RCIS, FSICP, and Laura...
We have all been there: p-waves casually marching across the monitor. Giving the patient orders to “Cough! Cough!” It is a stressful scenario and as the technologists frantically unwrap transcutaneous pacing electrodes and another circulator...
We have all been there: p-waves casually marching across the monitor. Giving the patient orders to “Cough! Cough!” It is a stressful scenario and as the technologists frantically unwrap transcutaneous pacing electrodes and another circulator...
We have all been there: p-waves...
10/03/2011
Cath Lab Digest
Clinical Update
03/03/2011
Michael S. Lee, MD, FACC, FSCAI, University of California, Los Angeles Medical Center, Los Angeles, California
Michael S. Lee, MD, FACC, FSCAI, Uni...
Orthotopic heart transplantation is an effective therapy for patients with end-stage congestive heart failure.1 Complications and comorbidities associated with orthotopic heart transplant and the medications needed to prevent rejection...
Orthotopic heart transplantation is an effective therapy for patients with end-stage congestive heart failure.1 Complications and comorbidities associated with orthotopic heart transplant and the medications needed to prevent rejection...
Orthotopic heart transplantation...
03/03/2011
Cath Lab Digest

Advertisement

Advertisement

Advertisement